HIGHLIGHTS
- who: Crohn`s Colitis and colleagues from the Medical University have published the research: Challenges in the Management of and Biologic Use in Incarcerated Patients With Inflammatory Bowel Disease, in the Journal: (JOURNAL)
- what: The authors aim to describe the clinical course of several incarcerated patients at the tertiary referral center and the obstacles impacting their clinical course.
SUMMARY
Therapies for moderate severity IBD involve either injection or infusion biologic therapy, though oral options are more available. The use of biologics requires frequent healthcare contact for optimal outcomes, a challenging reality . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.